Total Funding
50
68
Total FundingConvertible Note raised
Growth Score
-3 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
19811
Genomics, A.I., Cancer Diagnostics, Liquid Biopsy
Johannes Bhakdi: Chief Executive OfficerPast Role: i2X, Chief Executive Officer
About the Company
Quantgene is a biotechnology company focused on unlocking the deep human genome. They specialize in delivering more complete personalized medical intelligence using next generation genomic sequencing combined with cloud and AI technologies. Quantgene's technologies allow physicians to act proactively get ahead of potential diseases like
cancer, inherited conditions and lifestyle risks.
Women Founded
